Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

BrainCool

0.52 SEK

0.00 %

Less than 1K followers

BRAIN

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
0.00 %
-9.49 %
-44.89 %
-65.77 %
-60.91 %
-62.39 %
-65.87 %
-86.94 %
-70.74 %

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

Read more
Market cap
174.67M SEK
Turnover
218.2K SEK
Revenue
39.96M
EBIT %
-105.58 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release12/1/2025, 2:53 PM

BrainCool publishes information document regarding rights issue

BrainCool
Regulatory press release11/26/2025, 11:35 AM

Communiqué from extraordinary general meeting in BrainCool

BrainCool
Regulatory press release10/24/2025, 6:05 AM

NOTICE OF EXTRA GENERAL MEETING IN BRAINCOOL AB (PUBL)

BrainCool

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release10/24/2025, 6:00 AM

BrainCool carries out a rights issue of approximately SEK 42 million which is fully covered by subscription undertakings and advances publication of Q3 report

BrainCool
Regulatory press release8/15/2025, 6:00 AM

BrainCool AB (publ) - Financial Report for Q2 2025

BrainCool
Regulatory press release5/2/2025, 6:00 AM

ZOLL® orders custom-built IQool Tabletops to accelerate sales

BrainCool
Regulatory press release2/25/2025, 7:00 AM

BrainCool receives an order for 10 demo versions of BrainCool™ System from ZOLL®

BrainCool
Regulatory press release2/18/2025, 7:00 AM

BrainCool receives orders for consumable products to a value of SEK 8 million

BrainCool
Regulatory press release2/11/2025, 7:00 AM

BrainCool AB (publ) - Year End Report 2024

BrainCool
Regulatory press release2/4/2025, 7:00 AM

BrainCool receives market approval for BrainCool™ System in Malaysia

BrainCool
Regulatory press release1/8/2025, 7:02 AM

Karolinska expands PRINCESS 2 with BrainCool's product RhinoChill® System to additional countries, first patient outside of Sweden included

BrainCool
Regulatory press release12/20/2024, 7:25 AM

BrainCool AB (publ) adds two centers to the COTTIS 2 clinical study of its cooling systems in stroke patients

BrainCool
Regulatory press release12/3/2024, 2:10 PM

BrainCool appoints Jens Lindberg as new Chairman of the Board

BrainCool
Regulatory press release11/1/2024, 7:00 AM

BrainCool AB (publ) - Financial Report for Q3 2024

BrainCool
Regulatory press release9/23/2024, 6:39 AM

BrainCool AB (publ) cancels the loan agreement with EIB, as it is no longer appropriate for the company

BrainCool
Regulatory press release8/15/2024, 6:00 AM

BrainCool AB (publ) - Financial Report for Q2 2024

BrainCool
Regulatory press release7/5/2024, 9:35 AM

BrainCool AB (publ) – the first patient has been treated with RhinoChill® System in the pivotal COTTIS 2 study

BrainCool
Regulatory press release6/28/2024, 10:35 AM

BrainCool AB (publ) – the first patient can now be enrolled in the pivotal COTTIS 2 study

BrainCool
Regulatory press release6/26/2024, 11:50 AM

Braincool AB (publ): Bulletin from the annual general meeting

BrainCool
Press release6/18/2024, 9:13 AM

BioStock: BrainCool's new CEO on his visions for the company

BrainCool
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.